Clinical Trial Kits Market Size, Share & Trends Analysis Report By Service (Kitting Solutions, Logistics), By Phase (Phase I, Phase II, Phase III, Phase IV), By Region, And Segment Forecasts, 2021 - 2028
Clinical Trial Kits Market Growth & Trends
The global clinical trial kits market size is anticipated to reach USD 2.5 billion by 2028. The market is expected to expand at a CAGR of 8.5% from 2021 to 2028. The factors driving market expansion include globalization of clinical trials, increasing demand for remote services, and rising clinical trial complexity.
Remote clinical trial services are becoming increasingly essential in terms of patient retention, satisfaction, and safety.To enhance their capabilities, pharmaceutical companies have created a relationship with global logistics partners to provide direct-to-patient services.
These services provide participants with the flexibility and convenience of participating in the trials while remaining at home.
COVID-19 pandemic has affected the market which resulted in slowing down the trial process.The COVID-19 pandemic is rapidly boosting advances in medical practices that allow people to connect with the healthcare system remotely.
This effort of examining the patients at their homes has raised interest in at-home sample collection and testing. Such services offer convenience and minimize potential exposure to SARS-CoV-2.
Companies began to move to provide direct-to-consumer testing digital services.More aspects of the testing process, from test ordering to sample collection, are already making their way into patients’ homes.
Besides, regulatory authorities have instantly given sponsors guidelines to resolve issues that have arisen during ongoing clinical studies. Changes such as the use of telemedicine, the elimination of non-essential visits and laboratory assessments, as well as diagnostic testing and sample collection, have allowed many studies to continue while ensuring patient safety during the pandemic.
Clinical Trial Kits Market Report Highlights • The logistics segment dominated the market and accounted for the largest revenue share of 54.9% in 2020. This is due to the increasing demand for services to simplify the logistics process in clinical trials • The phase III segment dominated the market and accounted for the largest revenue share of 53.4% in 2020 as phase III trials require a large number of participants • North America dominated the market in 2020 owing to favorable government support and the existence of a large number of companies offering innovative services in the U.S. • In Asia Pacific, the market is projected to witness the highest CAGR of 9.9% over the forecast period as the region is continuously growing in terms of clinical trials due to the vast population and developing technology
Our reports have been used by over 10K customers, including:
The global eClinical Solutions market is projected to reach USD 15.4 billion by 2026 from USD 8.3 billion in 2021 at a CAGR of 13.3%. Increasing operational costs and regulatory requirements associated with clinical research studies, government grants to support clinical trials, and growing R&D expenditure on drug development by pharma-biotech...
143 pages •
By The Business Research Company
• Oct 2021
Organ-On-Chip (OOC) Global Market Opportunities And Strategies To 2030: COVID-19 Impact and Recovery provides the strategists, marketers and senior management with the critical information they need to assess the global OOC market as it emerges from the COVID 19 shut down. Description: Where is the largest and fastest...
Forecasts by Type (Drug Development, Drug Discovery), by Phase (Preclinical Testing, Clinical Trials, Other), by End-user (Pharmaceutical, Biotechnology, Contract Research Organisations, Research Institutes, Other), by Function (Target Data, Sequencing & Target Data Analysis, Docking, Molecular Modelling, High Throughput Screening...
Progressive Multifocal Leukoencephalopathy (Infectious Disease) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Progressive Multifocal Leukoencephalopathy - Drugs In Development, 2021, provides an overview of the Progressive Multifocal Leukoencephalopathy...
Dermatomyositis (Musculoskeletal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Dermatomyositis - Drugs In Development, 2021, provides an overview of the Dermatomyositis (Musculoskeletal Disorders) pipeline landscape.Dermatomyositis is a rare...
Global PDGFR Inhibitors Market, Drug Sales & Clinical Trials Insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global PDGFR Inhibitors Market Opportunity Assessment: > USD 4 Billion • Market & Drug Sales Insight 2020 Till 2026 •...
Systemic Mastocytosis (Gastrointestinal) - Drugs in Development, 2021 Summary This latest Pharmaceutical and Healthcare disease pipeline guide Systemic Mastocytosis - Drugs In Development, 2021, provides an overview of the Systemic Mastocytosis (Gastrointestinal) pipeline landscape.Systemic mastocytosis...
Stem Cell Transplantation
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.